User menu

Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.

Bibliographic reference Léonard, Daniel ; Remue, Christophe ; Abbes Orabi, Nora ; van Maanen , Aline ; Danse, Etienne ; et. al. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.. In: Colorectal Disease, Vol. 18, no.6, p. O175-O184 (2016)
Permanent URL http://hdl.handle.net/2078.1/174726
  1. Heald, G Chir, 19, 253 (1998)
  2. Kapiteijn E., Putter H., van de Velde C. J. H., Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands, 10.1046/j.1365-2168.2002.02196.x
  3. Allaix Marco E., Fichera Alessandro, Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery, 10.1245/s10434-013-2966-x
  4. Peng Junjie, Ding Ying, Tu Shanshan, Shi Debing, Sun Liang, Li Xinxiang, Wu Hongbin, Cai Sanjun, Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers, 10.1371/journal.pone.0106344
  5. Valentini Vincenzo, van Stiphout Ruud G.P.M., Lammering Guido, Gambacorta Maria Antonietta, Barba Maria Cristina, Bebenek Marek, Bonnetain Franck, Bosset Jean-Francois, Bujko Krzysztof, Cionini Luca, Gerard Jean-Pierre, Rödel Claus, Sainato Aldo, Sauer Rolf, Minsky Bruce D., Collette Laurence, Lambin Philippe, Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials, 10.1200/jco.2010.33.1595
  6. Frédérique Peschaud, Stéphane Benoist, Catherine Julié, Alain Beauchet, Christophe Penna, Philippe Rougier, Nordlinger Bernard, The Ratio of Metastatic to Examined Lymph Nodes Is a Powerful Independent Prognostic Factor in Rectal Cancer : , 10.1097/sla.0b013e31818842ec
  7. Berger Adam C., Sigurdson Elin R., LeVoyer Thomas, Hanlon Alexandra, Mayer Robert J., Macdonald John S., Catalano Paul J., Haller Daniel G., Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes, 10.1200/jco.2005.02.8852
  8. Nelson H., Petrelli N., Carlin A., Couture J., Fleshman J., Guillem J., Miedema B., Ota D., Sargent D., Guidelines 2000 for Colon and Rectal Cancer Surgery, 10.1093/jnci/93.8.583
  9. Sobin Leslie H., Fleming Irvin D., TNM classification of malignant tumors, fifth edition (1997), 10.1002/(sici)1097-0142(19971101)80:9<1803::aid-cncr16>3.0.co;2-9
  10. Edge Stephen B., Compton Carolyn C., The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, 10.1245/s10434-010-0985-4
  11. Miller Eric D., Robb Bruce W., Cummings Oscar W., Johnstone Peter A. S., The Effects of Preoperative Chemoradiotherapy on Lymph Node Sampling in Rectal Cancer : , 10.1097/dcr.0b013e3182536d70
  12. Lykke J., Roikjaer O., Jess P., , Tumour stage and preoperative chemoradiotherapy influence the lymph node yield in Stages I-III rectal cancer: results from a prospective nationwide cohort study, 10.1111/codi.12521
  13. Penninckx F Roels S Leonard D et al Quality Assurance for Rectal Cancer, Phase 1: Good Clinical Practice for the Treatment of Rectal Cancer. KCE reports 69B (D/2007/10273/55). Brussels: Health Care Knowledge Centre (KCE) https://kce.fgov.be/sites/default/files/page_documents/d20071027355.pdf
  14. Dworak O., Keilholz L., Hoffmann A., Pathological features of rectal cancer after preoperative radiochemotherapy, 10.1007/s003840050072
  15. Contal Cécile, O'Quigley John, An application of changepoint methods in studying the effect of age on survival in breast cancer, 10.1016/s0167-9473(98)00096-6
  16. Mandrekar JN Mandrekar SJ Cha SS Cutpoint determination methods in survival analysis using SAS ® 2003
  17. Midi Habshah, Sarkar S.K., Rana Sohel, Collinearity diagnostics of binary logistic regression model, 10.1080/09720502.2010.10700699
  18. Van Steen Kristel, Curran Desmond, Kramer Jocelyn, Molenberghs Geert, Van Vreckem Ann, Bottomley Andrew, Sylvester Richard, Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection, 10.1002/sim.1358
  19. Burnham, 2nd Edition) Model Selection and Multimodel Inference: A Practical Information-Theoretical Approach (2002)
  20. Willaert Wouter, Mareel Marc, Van De Putte Dirk, Van Nieuwenhove Yves, Pattyn Piet, Ceelen Wim, Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon, 10.1016/j.ctrv.2013.09.013
  21. Chang G. J., Rodriguez-Bigas M. A., Skibber J. M., Moyer V. A., Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review, 10.1093/jnci/djk092
  22. Evans, Colorectal Dis, 10, 157 (2008)
  23. Scabini Stefano, Montecucco Fabrizio, Nencioni Alessio, Zoppoli Gabriele, Sartini Marina, Rimini Edoardo, Massobrio Andrea, De Marini Luisito, Poggi Alessandro, Boaretto Roberto, Romairone Emanuele, Ballestrero Alberto, Ferrando Valter, The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer, 10.1186/1477-7819-11-292
  24. Glynne-Jones R., Counsell N., Quirke P., Mortensen N., Maraveyas A., Meadows H. M., Ledermann J., Sebag-Montefiore D., Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control, 10.1093/annonc/mdu147
  25. Bosset Jean-François, Calais Gilles, Mineur Laurent, Maingon Philippe, Stojanovic-Rundic Suzana, Bensadoun René-Jean, Bardet Etienne, Beny Alexander, Ollier Jean-Claude, Bolla Michel, Marchal Dominique, Van Laethem Jean-Luc, Klein Vincent, Giralt Jordi, Clavère Pierre, Glanzmann Christoph, Cellier Patrice, Collette Laurence, Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study, 10.1016/s1470-2045(13)70599-0
  26. QUASAR Collaborative Group, Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study, 10.1016/s0140-6736(07)61866-2
  27. Dekker J.W.T., Peeters K.C., Putter H., Vahrmeijer A.L., van de Velde C.J.H., Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification, 10.1016/j.ejso.2010.09.007
  28. Lee S.D., Kim T.H., Kim D.Y., Baek J.Y., Kim S.Y., Chang H.J., Park S.C., Park J.W., Oh J.H., Jung K.H., Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection, 10.1016/j.ejso.2012.03.002
  29. Madbouly Khaled M., Abbas Khaled S., Hussein Ahmed M., Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study, 10.1016/j.amjsurg.2013.07.022
  30. Kang Jeonghyun, Hur Hyuk, Min Byung Soh, Lee Kang Young, Kim Nam Kyu, Prognostic impact of the Lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation, 10.1002/jso.21913
  31. Kim Young Seok, Kim Jong Hoon, Yoon Sang Min, Choi Eun Kyung, Ahn Seung Do, Lee Sang-wook, Kim Jin Cheon, Yu Chang Sik, Kim Hee Chul, Kim Tae Won, Chang Heung Moon, Lymph Node Ratio as a Prognostic Factor in Patients With Stage III Rectal Cancer Treated With Total Mesorectal Excision Followed by Chemoradiotherapy, 10.1016/j.ijrobp.2008.08.065
  32. Rosenberg Robert, Friederichs Jan, Schuster Tibor, Gertler Ralf, Maak Matthias, Becker Karen, Grebner Anne, Ulm Kurt, Höfler Heinz, Nekarda Hjalmar, Siewert Jörg-Rüdiger, Prognosis of Patients With Colorectal Cancer Is Associated With Lymph Node Ratio : A Single-Center Analysis of 3026 Patients Over a 25-Year Time Period, 10.1097/sla.0b013e318190eddc
  33. Moug S J, Saldanha J D, McGregor J R, Balsitis M, Diament R H, Positive lymph node retrieval ratio optimises patient staging in colorectal cancer, 10.1038/sj.bjc.6605049
  34. Kim Ji-Yoon, Chung Su-Mi, Choi Byung-Ock, Lee In-Kyu, An Chang-Hyeok, Won Jong-Man, Ryu Mi-Ryeong, Prognostic Signifi cance of the Lymph Node Ratio Regarding Recurrence and Survival in Rectal Cancer Patients Treated with Postoperative Chemoradiotherapy, 10.5009/gnl.2012.6.2.203
  35. Sinicrope Frank A., Shi Qian, Smyrk Thomas C., Thibodeau Stephen N., Dienstmann Rodrigo, Guinney Justin, Bot Brian M., Tejpar Sabine, Delorenzi Mauro, Goldberg Richard M., Mahoney Michelle, Sargent Daniel J., Alberts Steven R., Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes, 10.1053/j.gastro.2014.09.041
  36. García-Granero Eduardo, Faiz Omar, Muñoz Elena, Flor Blas, Navarro Samuel, Faus Carmen, García-Botello Stephannie Anne, Lledó Salvador, Cervantes Andrés, Macroscopic assessment of mesorectal excision in rectal cancer : A useful tool for improving quality control in a multidisciplinary team, 10.1002/cncr.24387
  37. Leite J. S., Martins S. C., Oliveira J., Cunha M. F., Castro-Sousa F., Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer : Macroscopic completeness of mesorectal resection, 10.1111/j.1463-1318.2009.02153.x
  38. Maslekar Sushil, Sharma Abhiram, MacDonald Alistair, Gunn James, Monson John R. T., Hartley John E., Mesorectal Grades Predict Recurrences After Curative Resection for Rectal Cancer : , 10.1007/s10350-006-0756-2
  39. Nagtegaal Iris D., van de Velde Cornelis J.H., van der Worp Erik, Kapiteijn Ellen, Quirke Phil, van Krieken J. Han J.M., , Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control, 10.1200/jco.2002.07.010
  40. Quirke Phil, Steele Robert, Monson John, Grieve Robert, Khanna Subhash, Couture Jean, O'Callaghan Chris, Myint Arthur Sun, Bessell Eric, Thompson Lindsay C, Parmar Mahesh, Stephens Richard J, Sebag-Montefiore David, Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial, 10.1016/s0140-6736(09)60485-2